Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

The winter storm has brought heavy snow and ice to the region, impacting operations at Rick Husband Amarillo International ...

The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

Scotland has the highest rate of drugs deaths in Europe, with fatalities rising by 12% in a year to 1,172 drug-related deaths ...

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic obstructive pulmonary disease (COPD).

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

The Thistle drug consumption room - the first of its kind in the UK - will open in Glasgow on Monday in a bid to drive down ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...

Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million ...